BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23707513)

  • 1. NCL disease mechanisms.
    Palmer DN; Barry LA; Tyynelä J; Cooper JD
    Biochim Biophys Acta; 2013 Nov; 1832(11):1882-93. PubMed ID: 23707513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
    Kmoch S; Stránecký V; Emes RD; Mitchison HM
    Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
    Warrier V; Vieira M; Mole SE
    Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses.
    Uusi-Rauva K; Blom T; von Schantz-Fant C; Blom T; Jalanko A; Kyttälä A
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathomechanisms in the neuronal ceroid lipofuscinoses.
    Nelvagal HR; Lange J; Takahashi K; Tarczyluk-Wells MA; Cooper JD
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165570. PubMed ID: 31678162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
    Kollmann K; Uusi-Rauva K; Scifo E; Tyynelä J; Jalanko A; Braulke T
    Biochim Biophys Acta; 2013 Nov; 1832(11):1866-81. PubMed ID: 23402926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
    Butz ES; Chandrachud U; Mole SE; Cotman SL
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuronal ceroid lipofuscinoses: the same, but different?
    Cooper JD
    Biochem Soc Trans; 2010 Dec; 38(6):1448-52. PubMed ID: 21118105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuronal ceroid-lipofuscinoses: from past to present.
    Haltia M
    Biochim Biophys Acta; 2006 Oct; 1762(10):850-6. PubMed ID: 16908122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of model organisms for the study of neuronal ceroid lipofuscinosis.
    Bond M; Holthaus SM; Tammen I; Tear G; Russell C
    Biochim Biophys Acta; 2013 Nov; 1832(11):1842-65. PubMed ID: 23338040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal ceroid lipofuscinoses.
    Jalanko A; Braulke T
    Biochim Biophys Acta; 2009 Apr; 1793(4):697-709. PubMed ID: 19084560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.
    Kyttälä A; Lahtinen U; Braulke T; Hofmann SL
    Biochim Biophys Acta; 2006 Oct; 1762(10):920-33. PubMed ID: 16839750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis.
    Cooper JD; Russell C; Mitchison HM
    Biochim Biophys Acta; 2006 Oct; 1762(10):873-89. PubMed ID: 17023146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuronal ceroid-lipofuscinoses: a historical introduction.
    Haltia M; Goebel HH
    Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.
    Guo J; Johnson GS; Brown HA; Provencher ML; da Costa RC; Mhlanga-Mutangadura T; Taylor JF; Schnabel RD; O'Brien DP; Katz ML
    Mol Genet Metab; 2014 Aug; 112(4):302-9. PubMed ID: 24953404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular models of Batten disease.
    Minnis CJ; Thornton CD; FitzPatrick LM; McKay TR
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165559. PubMed ID: 31655107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.
    Cooper JD
    Curr Opin Neurol; 2003 Apr; 16(2):121-8. PubMed ID: 12644737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
    Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
    Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.
    Mukherjee AB; Appu AP; Sadhukhan T; Casey S; Mondal A; Zhang Z; Bagh MB
    Mol Neurodegener; 2019 Jan; 14(1):4. PubMed ID: 30651094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.